Dr. Mira Roganovic, MD

Dr. Roganovic practices at Dignity Health Advanced Imaging - Elk Grove in Elk Grove, California.

Dr. Roganovic's NPI, 1033154448, was assigned on June 19, 2006. Dr. Roganovic holds New York license 001720.

Dr. Roganovic's primary practice is Dignity Health Advanced Imaging - Elk Grove, at 8220 Wymark Dr. Suite 101, Elk Grove, CA 95757. The practice phone is (916) 464-7600.

Dr. Roganovic's primary practice is Dignity Health Advanced Imaging - Elk Grove in Elk Grove, California. Dr. Roganovic is also affiliated with Dignity Health - Mercy General Hospital. The medical group on file is Mercy Medical Group. Dmand AI also links Dr. Roganovic to 1 more hospital, 4 home health agencies and 1 group practice or clinic, each named with a free account. Dr. Roganovic's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roganovic practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Roganovic's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Roganovic is licensed in New York.

CMS data shows 1,339 Medicare services from Dr. Roganovic across 18 procedure codes in 2024, for 352 Medicare patients. Medicare paid $126,156 for them. Every service was in an office.

CMS counts 352 Medicare patients who saw Dr. Roganovic in 2024. The largest group is 65 to 74, with 145 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Roganovic's median patient age at 60, with 80% women.

In 2024, Dr. Roganovic wrote 7,933 Medicare Part D claims for 621 patients. 89% of them were for generic drugs. CMS names the drug for 7,278 of them, across 119 drugs with 11 or more claims each, at $465,919 in total drug cost. In 2023, CMS named 6,825 claims across 115 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Roganovic for performance year 2024, reported through an alternative payment model (APM). Dr. Roganovic accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Roganovic as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 2 general payments to Dr. Roganovic from 2 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $19.